David Shapiro Net Worth & Insider Trades

David Shapiro - Chief Medical Officer, Intercept Pharmaceuticals, Inc

As of May 3, 2019

What is David Shapiro's Net Worth?

The current estimated net worth of Intercept Pharmaceuticals, Inc's Chief Medical Officer, David Shapiro, is estimated to be about $37.56M . David Shapiro owns about 39,499 units of Intercept Pharmaceuticals, Inc common stock. In the last 7 years at Intercept Pharmaceuticals, Inc, David Shapiro has sold an estimated value of $37.52M worth.

What is David Shapiro's Past Insider Trading?

David Shapiro's largest purchase order was 8,917 units , worth over $92.74K on March 19, 2014. David Shapiro's largest sale order was 10,000 units , worth over $2.94M on August 29, 2014. In total, David Shapiro has made about 78 transactions over 7 years of their time at Intercept Pharmaceuticals, Inc. David Shapiro usually trades in January, with the busiest year in 2015. The most recent transaction was a sale order of 2,000 units , worth over $172.56K on May 3, 2019.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

David Shapiro

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is David Shapiro's' Mailing Address?

  • Mailing address is C/o Intercept Pharmaceuticals, Inc. 18 Desbrosses St. New York NY 10013 NY

Intercept Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Mark Pruzanski, M.D., 2020 $757,850 - $4,113,504 $1,015,996 $531,995 $7,660 $6,427,005
Mark Pruzanski, M.D., 2019 $734,292 - $4,197,742 $1,116,118 $560,265 $7,368 $6,615,785
Mark Pruzanski, M.D., 2018 $702,000 - $1,667,718 $1,705,358 $442,260 $8,623 $4,525,960
Jerome Durso, 2020 $599,524 - $2,057,016 $998,776 $231,737 $21,910 $3,908,963
Jerome Durso, 2019 $573,250 - $2,089,570 $1,238,321 $359,284 $21,368 $4,281,793
Jerome Durso, 2018 $540,800 - $1,554,326 $775,844 $292,032 $22,403 $3,185,406
Sandip Kapadia, 2020 $476,863 - $1,087,836 $528,088 $184,039 $21,910 $2,298,736
Sandip Kapadia, 2019 $464,100 - $1,001,664 $586,573 $252,935 $21,368 $2,326,640
Sandip Kapadia, 2018 $442,000 - $790,164 $393,544 $228,735 $22,403 $1,876,846
Richard Kim, 2020 $456,095 - $1,044,360 $505,128 $168,056 $79,211 $2,252,850
Richard Kim, 2019 $442,900 $202,800 $890,368 $521,398 $265,519 $76,343 $2,399,328
Lisa Bright, 2020 $480,552 - $925,704 $453,467 $240,955 $139,106 $2,239,784
Ryan Sullivan, 2020 $437,107 - $1,087,836 $528,088 - $89,942 $2,142,973
Ryan Sullivan, 2019 $445,520 - $1,471,902 $871,713 $267,089 $21,368 $3,077,592
Ryan Sullivan, 2018 $376,158 - $1,239,112 $1,190,351 $229,122 $173,437 $3,208,180
Christian Weyer, M.D., M.A.S., 2020 $486,731 - $925,704 $453,467 $170,804 $21,910 $2,058,616
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1270073/000110465921055639/tm218121-2_def14a.htm

What are Intercept Pharmaceuticals, Inc's Past Insider Trades?

Intercept Pharmaceuticals, Inc's most recent insider trade came on March 12, 2021 by Srinivas Akkaraju who bought 237,000 units worth $5.02M . In the last 9 years, insiders at Intercept Pharmaceuticals, Inc have sold an estimated value of $1.66B and bought an estimated value of $148.73M worth of shares. Insider trading is most common in January, with the busiest year in 2019. The most active traders at the company are David Shapiro, Chief Medical Officer,  Mark Pruzanski, Director,  and Lisa Bright, President .

INTERCEPT PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...